I guess we need to ask ourselves is are the fundamentals underpinning AHZ still solid? Does the proposed consolidation affect those fundamentals? Personally, I feel CardioCel will grow revenue substantially over the medium to long term, and the vaccines provide enormous potential for future growth and profit. The fundamentals being unaffected, I'll continue not only to hold, but accumulate as circumstance allows. You may feel differently, and hence vote and manage your investment as you see fit.
As some have commented, the share price may very well take a hit if the consolidation happens. I would be disappointed and annoyed if that happens, but it doesn't alter why I invested in AHZ. My sentiment hasn't changed since my initial investment and it won't be changed by approval or not of the consolidation.
Finally, is the consolidation a good idea? I honestly don't know, but I think with approximately 1.84B shares issued, a consolidation would be required sooner or later. Only time will tell whether it was a good idea now.
This is only my take on the situation, and certainly shouldn't be construed as any form of advice.
AHZ Price at posting:
6.8¢ Sentiment: Buy Disclosure: Held
